Ardelyx Inc. Wins U.S. Regulatory Approval for Groundbreaking Kidney Disease Treatment
Ardelyx Inc. has won U.S. regulatory approval for a groundbreaking treatment for chronic kidney disease, addressing elevated phosphorus levels.
Ardelyx Inc. has won U.S. regulatory approval for a groundbreaking treatment for chronic kidney disease, addressing elevated phosphorus levels.
United Airlines exceeds expectations with strong third-quarter earnings, recording a profit of $1.1 billion. They anticipate lower profits in the comi...
Activist investor Ancora Alternatives LLC believes Forward Air Corp.'s stock could double if shareholders vote against the Omni Logistics deal, leadin...
Evelo Biosciences Inc. reviews strategic options and explores partnerships following the failure of a Phase 2 study. The company remains hopeful about...
Goldman Sachs is set to report its third-quarter profit, with expectations of lower earnings and revenue amidst recent stock price volatility. Investo...
DexCom stock has experienced a decline due to concerns about weight loss drugs affecting demand for glucose monitoring devices. But is this decline a...
The U.N. Security Council has rejected a Russian resolution on violence and terrorism, revealing divisions and concerns over the recent Hamas attack....
A former FTX executive testifies against the cryptocurrency exchange's founder at a fraud trial, exposing reckless expenditures and a $13 billion shor...
BATM Advanced Communications announces expanded partnership with NGA 911 to deploy Edgility platform for edge computing in the United States.
President Joe Biden announces a $7 billion federal investment in hydrogen hubs across the US to advance clean energy and create jobs. The hubs will ac...